| Serial Number | 99299946 |
| Word Mark | DYRUPEG |
| Filing Date | Wednesday, July 23, 2025 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Wednesday, July 23, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Medicinal preparations for use in reducing the duration and incidence of neutropenia and febrile neutropenia, reducing the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils, and stimulating white blood cell production; Pharmaceutical preparations for use in reducing the duration and incidence of neutropenia and febrile neutropenia, reducing the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils, and stimulating white blood cell production; Pharmaceutical preparations for use in reducing the duration and incidence of neutropenia and febrile neutropenia, reducing the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils, and stimulating white blood cell production, namely, in the form of injectable pharmaceutical solutions; Pharmaceutical preparations for use in reducing the duration and incidence of neutropenia and febrile neutropenia, reducing the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils, and stimulating white blood cell production, namely, in the form of biopharmaceutical preparations; Pharmaceutical preparations for use in reducing the duration and incidence of neutropenia and febrile neutropenia, reducing the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils, and stimulating white blood cell production, namely, in the form of biopharmaceutical preparations and substances, namely, polypeptides, proteins, and monoclonal antibodies |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 24, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CURATEQ BIOLOGICS PRIVATE LIMITED |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | HYDERABAD KNOWLEDGE CITY 500032 IN |
| Event Date | Event Description |
| Wednesday, July 23, 2025 | NEW APPLICATION ENTERED |
| Wednesday, July 23, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, July 23, 2025 | APPLICATION FILING RECEIPT MAILED |